The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10240 malaria professionals are enjoying the free benefits of MalariaWorld today

vivax malaria

Singultus as an Unusual Debut of Plasmodium vivax Malaria

November 19, 2019 - 15:14 -- Open Access
Guadarrama-Conzuelo F, Saad Manzanera AD.
Cureus. 2019 Sep 1;11(9):e5548.

We describe this previously unreported association, hypothesize on the potential mechanism and review the literature on singultus and unusual presentations of Plasmodium infections.

Misperceptions of patients and health workers regarding malaria elimination in the Brazilian Amazon: a qualitative study

July 8, 2019 - 16:58 -- Open Access
Felipe Leão Gomes Murta, Maxwell Oliveira Mendes, Vanderson Souza Sampaio, Abrahim Sena Baze Junior, Ximena Pamela Díaz-Bermúdez, Wuelton Marcelo Monteiro and Marcus Vinícius Guimarães Lacerda
Malaria Journal 2019 18:223, 4 July 2019

Brazil has considerably reduced the number of cases of malaria in recent years and aims to eradicate the disease completely, however, vivax malaria continues to be a major challenge for the health system. In this context, the key to building a successful elimination programme may lie in the knowledge and the perceptions of the health agents, the patients affected by the disease and the personnel responsible for malaria diagnosis, treatment and control at the local level.

Factors associated with children’s health facility visits for primaquine treatment in rural Papua New Guinea

February 21, 2019 - 16:30 -- Open Access
Akiko Yoshii, Makoto Sekihara, Takuro Furusawa, Francis Hombhanje and Takahiro Tsukahara
Malaria Journal 2019 18:42, 20 February 2019

Few children received PQ treatment during the second visit to HFs following diagnosis of potential non-falciparum malaria.

Medical Treatment: 

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients

November 15, 2018 - 15:00 -- Open Access
Sara Avalos, Rosa E. Mejia, Gustavo Fontecha, et al.
Malaria Journal 2018 17:415

The findings support that the intake of PQ during 14 days of treatment against vivax malaria is safe in patients with a class III variant of G6PDd. In view of the new national regulations in the shortened treatment of vivax malaria for 7 days, it is advisable to be alert of potential cases of severe haemolysis that could occur among G6PD deficient hemizygous males with a class II mutation such as the Santamaria variant, previously reported in the country.

Diversity pattern of Duffy binding protein sequence among Duffy-negatives and Duffy-positives in Sudan

August 21, 2018 - 14:34 -- Open Access
Mohammad Rafiul Hoque, Mohammed Mohieldien Abbas Elfaki, Md Atique Ahmed, Seong-Kyun Lee, Fauzi Muh, Musab M. Ali Albsheer, Muzamil Mahdi Abdel Hamid and Eun-Taek Han
Malaria Journal 2018 17:297, 17 August 2018

This is the first pvdbp genetic diversity study from an African country. Sudanese isolates display high haplotype diversity and the gene is under selective pressure.


Malaria control and chemoprophylaxis policy in the Republic of Korea Armed Forces for the previous 20 years (1997–2016)

August 15, 2018 - 16:33 -- Open Access
Jae Hyoung Im, Kyungmin Huh, Chang-Gyo Yoon, Hyeongtaek Woo, Jin-Soo Lee, Moon-Hyun Chung, Terry A. Klein and Jaehun Jung
Malaria Journal 2018 17:295, 15 August 2018

The resurgence of vivax malaria in the ROK Armed Forces personnel near the DMZ was successfully suppressed through the implementation of a mass malaria chemoprophylaxis programme initiated by the MND in 1997, as well as several other factors that may have contributed to the reduction of malaria transmission since 2000.

Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia

October 26, 2016 - 17:22 -- Open Access
Karen Kerkhof, Vincent Sluydts, Lies Durnez, et al.
Malaria Journal 2016 15:510, 19 October 2016

It is possible to identify similar malaria pockets of higher malaria transmission together with the potential risk factors by using serology instead of PCR prevalence or malaria incidence data.

Distribution of malaria vectors and incidence of vivax malaria at Korean army installations near the demilitarized zone, Republic of Korea

May 11, 2016 - 16:10 -- Open Access
Kyu Sik Chang, Dae-Hyun Yoo, Young Ran Ju, Wook Gyo Lee, Jong Yul Roh, Heung-Chul Kim, Terry A. Klein and E-Hyun Shin
Malaria Journal 2016 15:259, 5 May 2016

The number of Anopheles spp. positive for P. vivax sporozoites correlated with the monthly number of malaria cases and exposure of ROKA soldiers from May–October to P. vivax malaria infections.

NOT Open Access | Cytokine modulation of human blood viscosity from vivax malaria patients

April 7, 2016 - 18:05 -- NOT Open Access
Edson Fredulin Scherer, Déborah Giovanna Cantarini, Renan Siqueira, Elton Brito Ribeiro, Érika Martins Braga, Adenilda Cristina Honório-França, Eduardo Luzía França
Acta Tropica, Volume 158, June 2016, Pages 139–147

Malaria is a major infectious disease in several countries and is caused by protozoa of the genus Plasmodium.


Subscribe to RSS - vivax malaria